Minimal residual disease in multiple myeloma: Benefits of flow cytometry

By  

International Journal Of Laboratory Hematology, Vol. 40, Iss. 1, 2018-02 ,pp. : 12-20

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quantitation of minimal residual disease in multiple myeloma using an allele-specific real-time PCR assay

By Rasmussen T.   Poulsen T.S.   Honore L.   Johnsen H.E.  

Experimental Hematology, Vol. 28, Iss. 9, 2000-09 ,pp. : 1039-1045

Elsevier

Access to resources Recommend Favorite

Minimal residual disease and normalization of the bone marrow after long-term treatment with alpha-interferon2b in polycythemia vera. A report on molecular response patterns in seven patients in sustained complete hematological remission

By Larsen Thomas Stauffer   Møller Michael Boe   de Stricker Karin   Nørgaard Peter   Samuelsson Jan   Marcher Claus   Andersen Morten T.   Bjerrum Ole Weis   Hasselbalch Hans Carl  

Hematology, Vol. 14, Iss. 6, 2009-12 ,pp. : 331-334

Maney Publishing

Access to resources Recommend Favorite

Monitoring of minimal residual disease in acute myeloid leukemia with t(8;21)(q22;q22)

By Zhang Lixia  

International Journal of Hematology, Vol. 97, Iss. 6, 2013-06 ,pp. : 786-792

Springer Publishing Company

Access to resources Recommend Favorite

Detection of Clonal Immunoglobulin and T-Cell Receptor Gene Recombination in Hematological Malignancies: Monitoring Minimal Residual Disease

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 9, Iss. 2, 2009-06 ,pp. : 124-135

Bentham Science Publishers

Access to resources Recommend Favorite